News
15 Jul, 2010
Category: 2010
Posted by: innocoll_admin
ASHBURN, Va., July 13, 2010 /PRNewswire/ -- Innocoll, Inc. announced that its wholly-owned subsidiary, Innocoll Technologies Ltd., has submitted a Special Protocol Assessment (SPA) for a proposed phase 3 clinical trial to support the US approval of Cogenzia™: Innocoll’s topical antibiotic therapy for the adjuvant treatment of infected diabetic foot ulcers.
[More]
17 Jun, 2010
Category: 2010
Posted by: innocoll_admin
ASHBURN, Va., June 17, 2010 /PRNewswire/ –– –Innocoll Inc. today announced that its board of directors appointed Anthony H. Wild, Ph.D. to the post of chairman of the board, effective immediately. Dr. Wild succeeds Rolf Schmidt who will remain on the board after serving as chairman since the company’s inception.
[More]